PFE - Pfizer Inc.

NYSE - NYSE Delayed Price. Currency in USD

Pfizer Inc.

235 East 42nd Street
New York, NY 10017
United States
212-733-2323
http://www.pfizer.com

SectorHealthcare
IndustryDrug Manufacturers - Major
Full Time Employees90,200

Key Executives

NameTitlePayExercisedYear Born
Mr. Ian C. ReadChairman & CEO6.38M11.48M1954
Mr. Frank A. D'AmelioExec. VP of Bus. Operations & CFO3.24M6.11M1958
Mr. Albert Bourla D.V.M., DVM, Ph.D.COO & Director4.07M587.28k1962
Dr. Mikael DolstenPres of Worldwide R&D4.2M3.33M1959
Mr. John D. YoungGroup Pres of Pfizer Innovative Health4.42M1.15M1965
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Pfizer Inc. discovers, develops, manufactures, and sells healthcare products worldwide. It operates in two segments, Pfizer Innovative Health (IH) and Pfizer Essential Health (EH). The IH segment focuses on the development and commercialization of medicines and vaccines, and consumer healthcare products in various therapeutic areas, including internal medicine, vaccines, oncology, inflammation and immunology, and rare diseases, as well as consumer healthcare, such as over-the-counter brands comprising dietary supplements, pain management, gastrointestinal, and respiratory and personal care. This segment offers products primarily under the Prevnar 13/Prevenar 13, Xeljanz, Eliquis, Lyrica, Enbrel, Ibrance, Xtandi, Advil, and Centrum brands. The EH segment offers products that would lose or have lost marketing patent protection; branded generic products; generic sterile injectable products; biosimilars; and anti-infectives. It provides products under the Lipitor, Premarin family, Norvasc, Lyrica, Celebrex, Viagra, Inflectra/Remsima, Pristiq, Zyvox, Vfend, Revatio, Inspra, Medrol, Sulperazon, Fragmin, Tygacil, Nivestim, and Retacrit brand names. This segment also engages in the research and development, as well as contract manufacturing activities. Pfizer Inc. has collaboration and/or co-promotion agreements with Bristol-Myers Squibb Company for the development of Eliquis; Astellas Pharma US, Inc. for developing Xtandi; Merck KGaA for the development of Bavencio; and Neofluidics, LLC to develop a microfluidics-based platform. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as centers for disease control and prevention. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Corporate Governance

Pfizer Inc.’s ISS Governance QualityScore as of June 1, 2018 is 1. The pillar scores are Audit: 1; Board: 6; Shareholder Rights: 1; Compensation: 3.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.